These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7814510)

  • 21. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
    de Ory F; Echevarría JM
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early acquisition of cytomegalovirus antibodies in communal settlements (kibbutzim) in Israel.
    Morag A; Zilberg J; Marva E
    Am J Epidemiol; 1984 Feb; 119(2):238-43. PubMed ID: 6320638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid diagnosis of acute Epstein-Barr virus infection by an indirect enzyme-linked immunosorbent assay for specific immunoglobulin M (IgM) antibody without rheumatoid factor and specific IgG interference.
    Ho DW; Field PR; Cunningham AL
    J Clin Microbiol; 1989 May; 27(5):952-8. PubMed ID: 2545744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
    Linde A; Andersson J; Lundgren G; Wahren B
    J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of antibodies to Epstein-Barr virus, cytomegalovirus and Toxoplasma in a Mexican highland community.
    Golubjatnikov R; Allen VD; Steadman M; Del Pilar Olmos Blanc ; Inhorn SL
    Am J Epidemiol; 1973 Feb; 97(2):116-24. PubMed ID: 4347509
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of antibodies to cytomegalovirus and Epstein-Barr virus in patients with autism spectrum disorder.
    Valayi S; Eftekharian MM; Taheri M; Alikhani MY
    Hum Antibodies; 2017; 26(3):165-169. PubMed ID: 29689713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus antibodies in multifocal choroiditis and panuveitis.
    Spaide RF; Sugin S; Yannuzzi LA; DeRosa JT
    Am J Ophthalmol; 1991 Oct; 112(4):410-3. PubMed ID: 1656755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne.
    Schmitz H; Kampa D; Heidenreich W
    Int J Cancer; 1975 Dec; 16(6):1030-4. PubMed ID: 172458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of the Enzygnost anti-EBV/IgG for the determination of the Epstein-Barr virus immune status in pediatric patients.
    Kleines M; Scheithauer S; Ritter K; Häusler M
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):247-9. PubMed ID: 16545933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association?
    Vergnon JM; Vincent M; de Thé G; Mornex JF; Weynants P; Brune J
    Lancet; 1984 Oct; 2(8406):768-71. PubMed ID: 6148520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of Epstein-Barr virus specific IgE antibody].
    Ohno I; Tanno Y; Takishima T; Ida S
    Arerugi; 1990 Jan; 39(1):42-7. PubMed ID: 2161645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
    Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological status to Epstein-Barr virus and cytomegalovirus in patients with genital condylomata.
    Zerbini M; Musiani M; Gentilomi G; Costa S; Poggi MG; La Placa M
    Eur J Epidemiol; 1989 Sep; 5(3):343-7. PubMed ID: 2551722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of immunoglobulin M antibody to Epstein-Barr virus by use of an enzyme-labeled antigen.
    Schmitz H
    J Clin Microbiol; 1982 Aug; 16(2):361-6. PubMed ID: 6288765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age distribution of Epstein-Barr virus, cytomegalovirus and rubella virus antibodies.
    Lin KH; Chiang CH; Yang CS
    Taiwan Yi Xue Hui Za Zhi; 1987 Dec; 86(12):1316-9. PubMed ID: 2832515
    [No Abstract]   [Full Text] [Related]  

  • 38. Guillain-Barré syndrome associated with Epstein-Barr virus in a cytomegalovirus-negative patient.
    Glaser R; Brennan R; Berlin CM
    Dev Med Child Neurol; 1979 Dec; 21(6):787-90. PubMed ID: 230116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Potential and limitations of serological Epstein-Barr virus diagnostics].
    Huzly D; Hess RD
    Dtsch Med Wochenschr; 2007 Jan; 132(4):151-4. PubMed ID: 17230331
    [No Abstract]   [Full Text] [Related]  

  • 40. Enzyme-linked immunosorbent assay (ELISA) for IgA and IgG antibodies to Epstein-Barr-virus ribonucleotide reductase in patients with nasopharyngeal carcinoma.
    Fones-Tan A; Chan SH; Tsao SY; Gan LH; Tan WH; Li B; Khong PW; Gan YY
    Int J Cancer; 1994 Dec; 59(6):739-42. PubMed ID: 7989110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.